Brian Goodman

Brian Goodman is an accomplished professional in the biotech industry with extensive experience in leadership roles since 2013. Currently a Partner and Principal at MPM BioImpact, Brian also serves as Cofounder and Board Director at ReNAgade Therapeutics, and as a Board Member at Antiva Biosciences, a clinical stage biotech company focusing on antivirals for HPV. Additionally, Brian is Cofounder and holds multiple executive positions at Aktis Oncology, and is involved with Orna Therapeutics as a Board Member and Interim VP of Business Development. Prior experiences include significant contributions at Evelo Biosciences, where Brian helped pioneer Oncobiotic™ therapies targeting cancer, and earlier positions in venture capital and research at Flagship Ventures and Harvard Medical School, respectively. Brian earned a PhD in Biochemistry from Harvard Medical School and a BS/BA in Biochemistry and Economics from Brandeis University.